Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Fassio

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|November 27, 2019
Osteoporosis in Rheumatic DiseasesGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
RMD Open|January 4, 2023
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)Giovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Rheumatology (Oxford, England)|January 20, 2021
Association between environmental air pollution and rheumatoid arthritis flaresGiovanni Adami, Ombretta Viapiana, Maurizio Rossini, et al.
Internal and Emergency Medicine|March 30, 2020
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunctionGiovanni Cioffi, Ombretta Viapiana, Luigi Tarantini, et al.
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Osteoporosis in 10 years time: a glimpse into the future of osteoporosisGiovanni Adami, Angelo Fassio, Davide Gatti, et al.
BMC Rheumatology|September 10, 2024
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritisGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|July 12, 2018
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitisGiovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Clinical and Experimental Rheumatology|November 13, 2018
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritisAngelo Fassio, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|November 27, 2019
Osteoporosis in Rheumatic DiseasesGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
RMD Open|January 4, 2023
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)Giovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Rheumatology (Oxford, England)|January 20, 2021
Association between environmental air pollution and rheumatoid arthritis flaresGiovanni Adami, Ombretta Viapiana, Maurizio Rossini, et al.
Internal and Emergency Medicine|March 30, 2020
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunctionGiovanni Cioffi, Ombretta Viapiana, Luigi Tarantini, et al.
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Osteoporosis in 10 years time: a glimpse into the future of osteoporosisGiovanni Adami, Angelo Fassio, Davide Gatti, et al.
BMC Rheumatology|September 10, 2024
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritisGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|July 12, 2018
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitisGiovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Clinical and Experimental Rheumatology|November 13, 2018
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritisAngelo Fassio, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Pageof 10